OTCMKTS:BETRF BetterLife Pharma (BETRF) Stock Price, News & Analysis $0.06 -0.01 (-10.77%) As of 07/3/2025 12:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About BetterLife Pharma Stock (OTCMKTS:BETRF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BetterLife Pharma alerts:Sign Up Key Stats Today's Range$0.06▼$0.0750-Day Range$0.06▼$0.0952-Week Range$0.05▼$0.15Volume750 shsAverage Volume11,613 shsMarket Capitalization$7.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Read More BetterLife Pharma Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks4th Percentile Overall ScoreBETRF MarketRank™: BetterLife Pharma scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for BetterLife Pharma. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of BetterLife Pharma is -5.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BetterLife Pharma is -5.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about BetterLife Pharma's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.07% of the float of BetterLife Pharma has been sold short.Short Interest Ratio / Days to CoverBetterLife Pharma has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in BetterLife Pharma has recently decreased by 0.67%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBetterLife Pharma does not currently pay a dividend.Dividend GrowthBetterLife Pharma does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.07% of the float of BetterLife Pharma has been sold short.Short Interest Ratio / Days to CoverBetterLife Pharma has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in BetterLife Pharma has recently decreased by 0.67%, indicating that investor sentiment is improving. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for BetterLife Pharma this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BetterLife Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders34.77% of the stock of BetterLife Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.01% of the stock of BetterLife Pharma is held by institutions.Read more about BetterLife Pharma's insider trading history. Receive BETRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address BETRF Stock News HeadlinesBetterLife Pharma Inc. (BETRF) Stock Price, Quote, News & Analysis - Seeking AlphaJune 28, 2025 | seekingalpha.comBetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001May 28, 2025 | finance.yahoo.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 5 at 2:00 AM | Porter & Company (Ad)BetterLife Pharma Inc.: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric DisordersMay 14, 2025 | finanznachrichten.deBetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric DisordersMay 14, 2025 | globenewswire.comBetterLife Pharma Inc.: BetterLife Announces Debt SettlementsMay 10, 2025 | finanznachrichten.deBetterLife Announces Debt SettlementsMay 6, 2025 | globenewswire.comBetterLife Pharma With CEO, Ahmad DoroudianApril 25, 2025 | msn.comSee More Headlines BETRF Stock Analysis - Frequently Asked Questions How have BETRF shares performed this year? BetterLife Pharma's stock was trading at $0.0720 at the beginning of the year. Since then, BETRF stock has decreased by 19.4% and is now trading at $0.0580. How do I buy shares of BetterLife Pharma? Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/05/2025Next Earnings (Estimated)9/23/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:BETRF CIK1464165 Webwww.abetterlifepharma.com Phone604-221-0595FaxN/AEmployees7Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.55 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-609.07% Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-1.45Miscellaneous Outstanding Shares129,460,000Free Float84,449,000Market Cap$7.51 million OptionableNot Optionable Beta1.45 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:BETRF) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BetterLife Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.